A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice

Jong-Kook Lee1, Seong-Cheol Park, Kyung-Soo Hahm

  • 1Research Center for Proteinaceous Materials (RCPM), Chosun University, Kwangju 501-759, Republic of Korea.

Biomaterials
|November 2, 2013
PubMed

Insights

A modified antimicrobial peptide, HPA3P2, shows significant effectiveness against multidrug-resistant Pseudomonas aeruginosa in vivo. This new peptide reduces inflammation and tissue damage, offering potential as a novel antibiotic treatment.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Multidrug-resistant microbes pose a significant global health threat.
  • Antimicrobial peptides (AMPs) are a promising alternative, with structural modifications enhancing efficacy and reducing toxicity.
  • HPA3, a modified AMP, exhibits cytotoxicity, while HPA3P shows reduced toxicity but limited in vivo antibacterial activity.

Purpose of the Study:

  • To design and evaluate a novel antimicrobial peptide, HPA3P2, with enhanced antibacterial activity and reduced cytotoxicity.
  • To investigate the mechanism of action of HPA3P2 against multidrug-resistant bacteria.

Main Methods:

  • Design of HPA3P2 with a helix-PXXP-helix structure via amino acid substitution (Pro at positions 9 and 12).
  • In vivo efficacy testing in ICR mice infected with multidrug-resistant Pseudomonas aeruginosa.
  • Evaluation of HPA3P2 in a mouse model of septic shock induced by P. aeruginosa LPS.

Main Results:

  • HPA3P2 demonstrated 100% survival in mice infected with multidrug-resistant P. aeruginosa at low doses.
  • HPA3P2 significantly reduced pro-inflammatory mediators and tissue damage in a septic shock model.
  • Mechanism of action involves targeting the lipopolysaccharide (LPS) on the bacterial outer membrane.

Conclusions:

  • HPA3P2 exhibits potent in vivo antibacterial activity against multidrug-resistant P. aeruginosa.
  • HPA3P2 demonstrates anti-inflammatory and tissue-protective effects.
  • HPA3P2 represents a promising therapeutic candidate for combating multidrug-resistant bacterial infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
225
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.7K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
163